Abstract
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical, and oncologic factors to the presence of elevated AFP levels in large cohort of patients with HCC.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 2150-2157 |
| Numero di pagine | 8 |
| Rivista | Cancer |
| Volume | 120 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- Adult
- Aged
- Alanine Transaminase
- Bilirubin
- Carcinoma, Hepatocellular
- Cohort Studies
- Female
- Hepatitis C
- Humans
- Italy
- Liver Cirrhosis
- Liver Function Tests
- Liver Neoplasms
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Serum Albumin
- Sex Factors
- Tumor Markers, Biological
- alanine aminotransferase
- alpha-Fetoproteins
- cirrhosis
- female
- oncology
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
